The effects of rhein on D-GalN/LPS-induced acute liver injury in mice: Results from gut microbiome-metabolomics and host transcriptome analysis

Shuhui Liu, Ruiying Yin, Ziwei Yang, Feili Wei, Jianhua HuFrontiers in Immunology 2022 · DOI

This study, published in Frontiers in Immunology, explores how rhein—a bioactive compound found in rhubarb—protects the liver from acute injury. By integrating gut microbiome sequencing, metabolomics, and host transcriptomics, the researchers demonstrate that rhein acts as a multi-target regulator, reshaping the gut-liver axis to reduce inflammation and metabolic distress.

TL;DR

Rhein significantly alleviates acute liver injury (ALI) in mice by restoring gut microbial balance (notably boosting protective Akkermansia), normalizing metabolic pathways, and modulating hepatic gene expression. The study highlights the "gut-liver axis" as a primary therapeutic target for traditional Chinese medicine.

What Problem Does This Paper Address?

Acute Liver Injury (ALI) is a severe condition characterized by rapid hepatocyte death and high mortality rates. Currently, liver transplantation is the primary treatment, but its availability is limited. While rhein (an anthraquinone extracted from rhubarb) is known for its anti-inflammatory and antioxidant properties, its specific mechanism in treating liver disease remained hazy.

The researchers set out to bridge this gap by investigating the gut-liver axis. They hypothesized that rhein doesn't just work on the liver directly; it might work "remotely" by altering the bacteria in our gut and the chemicals they produce, which then travel to the liver to promote healing.

Methods

The team used a multi-omics approach to triangulate the effects of rhein in a mouse model of ALI (induced by D-GalN/LPS):

  • Animal Model: C57BL/6 mice were divided into three groups: Normal Control (NC), Model (injury without treatment), and Rhein (100 mg/kg treatment).
  • 16S rRNA Gene Sequencing: Used to identify changes in the composition of the gut microbiota.
  • LC-MS Metabolomics: Untargeted profiling of stool samples to see which metabolic byproducts were altered by the injury and restored by rhein.
  • RNA-seq (Transcriptomics): Analysis of liver tissue to determine which host genes were being "turned on" or "off" in response to treatment.
  • Histology & Biochemistry: Standard checks of liver enzymes (ALT/AST) and tissue staining (HE) to confirm physical recovery.

Datasets

The study generated and analyzed several primary experimental datasets:

  • Microbiome data: 16S rRNA sequences identifying taxa at the phylum, family, and genus levels.
  • Metabolomic data: Profiles of 997 (negative mode) and 869 (positive mode) metabolites identified in feces.
  • Transcriptomic data: RNA-seq profiles of mouse liver tissue, identifying 5,220 differentially expressed genes (DEGs) in the injury model.
  • Public Databases: Results were cross-referenced with the Human Metabolome Database (HMDB), METLIN, and the KEGG pathway database.

Key Insights and Ideas

  • The Akkermansia Connection: One of the most striking findings was that rhein treatment significantly increased the abundance of Akkermansia and Bacteroidetes. Akkermansia muciniphila is considered a "next-generation probiotic" known for strengthening the intestinal barrier and reducing systemic inflammation.
  • Metabolic Restoration: The injury model showed a massive disruption in amino acid and lipid metabolism. Rhein didn't just change a few markers; it helped 126 different metabolites return toward normal levels, particularly those involved in taurine and glutathione metabolism (critical for antioxidant defense).
  • Gene Expression "Rescue": The researchers identified a core set of 1,907 genes that were disrupted by the liver injury but "rescued" by rhein. Specifically, rhein down-regulated pro-inflammatory genes like Tnf (Tumor Necrosis Factor) and Cxcl2, while up-regulating protective genes like Mfsd2a, which helps maintain the blood-brain (and potentially blood-liver) barrier.
  • Correlation is Key: The study used Spearman correlation heatmaps to show that the "good" bacteria (like Bacteroides) were directly correlated with the expression of protective host genes, suggesting a functional link between the bugs in the gut and the health of the liver.

Key Results

  • Biochemical Recovery: Rhein treatment significantly lowered plasma ALT and AST levels compared to the untreated model group.
  • Microbial Shift: The model group was dominated by Lachnoclostridium and Roseburia, but rhein reshaped the community to favor Verrucomicrobia (P < 0.01).
  • Metabolite Normalization: 36 metabolites showed statistically significant recovery after rhein treatment, including L-alpha-amino acids and ofloxacin-N-oxide.
  • Transcriptomic Impact: Rhein normalized the expression of 102 up-regulated and 9 down-regulated genes that are critical to the inflammatory response.

Limitations and Future Work

While the multi-omics approach is robust, the authors acknowledge a few limitations:

  • Causality: While the study shows strong correlations between gut bugs and liver health, it doesn't definitively prove that the bugs caused the recovery. Future work involving Fecal Microbiota Transplantation (FMT) is needed to confirm this.
  • Direct vs. Indirect Effects: It remains unclear how much of rhein’s effect is due to direct interaction with liver cells versus the indirect effect via the gut.
  • Clinical Translation: As with all mouse studies, the dosage and metabolic pathways in humans may differ, requiring clinical trials to validate these findings in human ALI patients.

Summary updated

Abstract

Overall, our results show that rhein alleviated D-GalN/LPS-induced acute liver injury in mice. It may help modulate gut microbiota in mice, thereby changing metabolism in the intestine. Meanwhile, rhein also may help regulate genes expression level to alleviate D-GalN/LPS-induced acute liver injury.
BibTeX
@inproceedings{liu2022effects,
  author = {Shuhui Liu and Ruiying Yin and Ziwei Yang and Feili Wei and Jianhua Hu},
  title = {{The effects of rhein on D-GalN/LPS-induced acute liver injury in mice: Results from gut microbiome-metabolomics and host transcriptome analysis}},
  booktitle = {Frontiers in Immunology},
  year = {2022},
  doi = {10.3389/fimmu.2022.971409},
}
Figure